Medicover AB (publ) (STO:MCOV.B)
Sweden · Delayed Price · Currency is SEK 241.50
-2.00 (-0.82%)
Aug 26, 2026, 5:29 PM CET
Medicover AB Income Statement
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 2,468 | 2,378 | 2,092 | 1,746 | 1,510 | 1,377 | |
Revenue Growth | 9.28% | 13.69% | 19.78% | 15.64% | 9.64% | 38.04% |
Cost of Revenue | 1,891 | 1,827 | 1,644 | 1,387 | 1,170 | 982.4 |
Gross Profit | 576.8 | 550.7 | 448.3 | 359.4 | 340.1 | 395 |
Selling, General & Admin | 399.6 | 394 | 358.7 | 297.5 | 271.4 | 232.4 |
Operating Expenses | 399.6 | 394 | 358.7 | 297.5 | 271.4 | 232.4 |
Operating Income | 177.2 | 156.7 | 89.6 | 61.9 | 68.7 | 162.6 |
Interest Expense | -65.5 | -64 | -58.8 | -51.4 | -34.5 | -20.1 |
Interest & Investment Income | 4.6 | 4.3 | 4.8 | 4.4 | 2.7 | 1 |
Earnings From Equity Investments | -0.1 | 0.1 | - | 0.1 | 0.2 | 1 |
Currency Exchange Gain (Loss) | -5.5 | 0.7 | 3.4 | 1.1 | -3.3 | 1.8 |
Other Non Operating Income (Expenses) | -1.2 | 0.7 | 0.4 | 0.2 | 2.4 | 0.3 |
EBT Excluding Unusual Items | 109.5 | 98.5 | 39.4 | 16.3 | 36.2 | 146.6 |
Merger & Restructuring Charges | -1.3 | -1 | -2.9 | -0.7 | -7.2 | -3.2 |
Impairment of Goodwill | - | - | -16.4 | - | - | - |
Gain (Loss) on Sale of Investments | -2.2 | -2.2 | - | - | -3.2 | 0.4 |
Gain (Loss) on Sale of Assets | 3.1 | 3.1 | - | 7.8 | - | - |
Asset Writedown | - | - | - | 0.2 | -6.3 | - |
Pretax Income | 109.1 | 98.4 | 20.1 | 23.6 | 19.5 | 143.8 |
Income Tax Expense | 28.7 | 25.7 | 5.5 | 5.2 | 5.8 | 37.2 |
Earnings From Continuing Operations | 80.4 | 72.7 | 14.6 | 18.4 | 13.7 | 106.6 |
Minority Interest in Earnings | 4.5 | 4.8 | 2.1 | -0.8 | -1.9 | -4.8 |
Net Income | 84.9 | 77.5 | 16.7 | 17.6 | 11.8 | 101.8 |
Net Income to Common | 84.9 | 77.5 | 16.7 | 17.6 | 11.8 | 101.8 |
Net Income Growth | 95.62% | 364.07% | -5.11% | 49.15% | -88.41% | 294.57% |
Shares Outstanding (Basic) | 151 | 151 | 150 | 149 | 149 | 148 |
Shares Outstanding (Diluted) | 151 | 151 | 150 | 150 | 149 | 148 |
Shares Change | 0.61% | 0.52% | 0.36% | 0.47% | 0.41% | 4.66% |
EPS (Basic) | 0.56 | 0.51 | 0.11 | 0.12 | 0.08 | 0.69 |
EPS (Diluted) | 0.56 | 0.51 | 0.11 | 0.12 | 0.08 | 0.69 |
EPS Growth | 94.43% | 360.59% | -5.48% | 49.16% | -88.48% | 276.93% |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | 186.3 | 185.6 | 139.6 | 94.5 | 29.6 | 114.5 |
Free Cash Flow Per Share | 1.23 | 1.23 | 0.93 | 0.63 | 0.20 | 0.77 |
Dividend Per Share | 0.200 | 0.200 | 0.150 | 0.120 | 0.120 | 0.120 |
Dividend Growth | 33.33% | 33.33% | 25.00% | 0% | 0% | 71.43% |
Gross Margin | 23.37% | 23.16% | 21.43% | 20.58% | 22.52% | 28.68% |
Operating Margin | 7.18% | 6.59% | 4.28% | 3.54% | 4.55% | 11.80% |
Profit Margin | 3.44% | 3.26% | 0.80% | 1.01% | 0.78% | 7.39% |
Free Cash Flow Margin | 7.55% | 7.80% | 6.67% | 5.41% | 1.96% | 8.31% |
EBITDA | 279.3 | 257.8 | 187.6 | 156.3 | 152.7 | 220.6 |
EBITDA Margin | 11.32% | 10.84% | 8.97% | 8.95% | 10.11% | 16.02% |
D&A For EBITDA | 102.1 | 101.1 | 98 | 94.4 | 84 | 58 |
EBIT | 177.2 | 156.7 | 89.6 | 61.9 | 68.7 | 162.6 |
EBIT Margin | 7.18% | 6.59% | 4.28% | 3.54% | 4.55% | 11.80% |
Effective Tax Rate | 26.31% | 26.12% | 27.36% | 22.03% | 29.74% | 25.87% |